Home › Funds › Maverick Capital › PCVX
Maverick Capital position in PCVX
VAXCYTE INC · Health Care
Latest position (Q2 2026)1.61M sh
Reported value held$93.78M
Portfolio Weight0.85%
First reportedQ1 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 355.13K | $24.26M | New |
| Q2 2024 | 687.91K | $51.94M | Add |
| Q3 2024 | 976.25K | $111.56M | Add |
| Q4 2024 | 1.20M | $98.39M | Add |
| Q1 2025 | 1.21M | $45.62M | Add |
| Q2 2025 | 1.31M | $42.61M | Add |
| Q3 2025 | 1.29M | $46.45M | Reduce |
| Q4 2025 | 1.35M | $62.48M | Add |
| Q1 2026 | 1.38M | $80.06M | Add |
| Q2 2026 | 1.61M | $93.78M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PCVX
- Fidelity Management & Research (FMR) 20.85M sh · $1.21B · Q2 2026
- Janus Henderson Group 16.58M sh · $960.23M · Q1 2026
- BlackRock Inc 12.07M sh · $701.52M · Q2 2026
- Vanguard Group 12.19M sh · $562.63M · Q4 2025
- Wellington Management Group 7.00M sh · $407.00M · Q2 2026
- Geode Capital Management 3.46M sh · $201.13M · Q2 2026
- D. E. Shaw & Co 1.90M sh · $110.56M · Q2 2026
- Charles Schwab Investment Management 1.46M sh · $85.15M · Q2 2026
- Goldman Sachs Group 1.38M sh · $79.98M · Q2 2026
- Northern Trust Corp 1.28M sh · $74.42M · Q2 2026
- Norges Bank Investment Management 1.25M sh · $72.42M · Q2 2026